In the last 12 months, insiders at CYTOKINETICS INC ($CYTK) filed 723 transactions with the SEC: 0 open-market purchases totaling $0 and 222 sales totaling $78,841,323. Net insider sentiment: net selling.
CYTOKINETICS INC operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Blum Robert I (President & CEO) — 179 transactions totaling $42,859,299
- Malik Fady Ibraham (EVP Research & Development) — 198 transactions totaling $24,935,320
- Callos Andrew (EVP, Chief Commercial Officer) — 78 transactions totaling $16,117,664
- Kaye Edward M. MD (Director) — 30 transactions totaling $4,007,673
- PARSHALL B LYNNE (Director) — 32 transactions totaling $3,467,750
View all SEC Filings for CYTOKINETICS INC (CYTK).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Blum Robert I | President & CEO | S | Common Stock | 7500 | $66.63 | 426,996.0000 | 122,264,929 | 1.73% | 0.01% |
| March 31, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 3639 | $65.00 | 66,004.0000 | 122,264,929 | 5.23% | 0.00% |
| March 17, 2026 | Blum Robert I | President & CEO | S | Common Stock | 23928 | $62.15 | 434,496.0000 | 122,264,929 | 5.22% | 0.02% |
| March 17, 2026 | Blum Robert I | President & CEO | S | Common Stock | 12673 | $62.15 | 458,424.0000 | 122,264,929 | 2.69% | 0.01% |
| March 17, 2026 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4397 | $62.15 | 153,902.0000 | 122,264,929 | 2.78% | 0.00% |
| March 17, 2026 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 7636 | $62.15 | 158,299.0000 | 122,264,929 | 4.60% | 0.01% |
| March 17, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 2916 | $62.15 | 71,573.0000 | 122,264,929 | 3.91% | 0.00% |
| March 17, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 5626 | $62.15 | 74,489.0000 | 122,264,929 | 7.02% | 0.00% |
| March 17, 2026 | Lee Sung | EVP, Chief Financial Officer | S | Common Stock | 4935 | $62.15 | 87,127.0000 | 122,264,929 | 5.36% | 0.00% |
| March 18, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 1930 | $62.07 | 78,185.0000 | 122,264,929 | 2.41% | 0.00% |
| March 15, 2026 | Lee Sung | EVP, Chief Financial Officer | A | Non-Qualified Stock Option (Right to Buy) | 29480 | $0.00 | 29,480.0000 | 122,264,929 | 9999.99% | 0.02% |
| March 15, 2026 | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 27306 | $0.00 | 165,935.0000 | 122,264,929 | 19.70% | 0.02% |
| March 15, 2026 | Malik Fady Ibraham | EVP Research & Development | A | Incentive Stock Option (Right to Buy) | 1665 | $0.00 | 1,665.0000 | 122,264,929 | 9999.99% | 0.00% |
| March 15, 2026 | Malik Fady Ibraham | EVP Research & Development | A | Non-Qualified Stock Option (Right to Buy) | 39527 | $0.00 | 39,527.0000 | 122,264,929 | 9999.99% | 0.03% |
| March 15, 2026 | Callos Andrew | EVP, Chief Commercial Officer | A | Incentive Stock Option (Right to Buy) | 1665 | $0.00 | 1,665.0000 | 122,264,929 | 9999.99% | 0.00% |
| March 15, 2026 | Hessekiel Jeffrey | Chief Legal & Admin Officer | A | Common Stock | 20646 | $0.00 | 107,943.0000 | 122,264,929 | 23.65% | 0.02% |
| March 15, 2026 | Callos Andrew | EVP, Chief Commercial Officer | A | Common Stock | 20646 | $0.00 | 68,504.0000 | 122,264,929 | 43.14% | 0.02% |
| March 15, 2026 | Blum Robert I | President & CEO | A | Incentive Stock Option (Right to Buy) | 1665 | $0.00 | 1,665.0000 | 122,264,929 | 9999.99% | 0.00% |
| March 15, 2026 | Blum Robert I | President & CEO | A | Non-Qualified Stock Option (Right to Buy) | 111864 | $0.00 | 111,864.0000 | 122,264,929 | 9999.99% | 0.09% |
| March 15, 2026 | Blum Robert I | President & CEO | A | Common Stock | 75258 | $0.00 | 471,097.0000 | 122,264,929 | 19.01% | 0.06% |
| March 15, 2026 | Lee Sung | EVP, Chief Financial Officer | A | Common Stock | 20646 | $0.00 | 92,062.0000 | 122,264,929 | 28.91% | 0.02% |
| March 15, 2026 | Hessekiel Jeffrey | Chief Legal & Admin Officer | A | Non-Qualified Stock Option (Right to Buy) | 22820 | $0.00 | 22,820.0000 | 122,264,929 | 9999.99% | 0.02% |
| March 15, 2026 | Hessekiel Jeffrey | Chief Legal & Admin Officer | A | Incentive Stock Option (Right to Buy) | 8325 | $0.00 | 8,325.0000 | 122,264,929 | 9999.99% | 0.01% |
| March 15, 2026 | Lee Sung | EVP, Chief Financial Officer | A | Incentive Stock Option (Right to Buy) | 1665 | $0.00 | 1,665.0000 | 122,264,929 | 9999.99% | 0.00% |
| March 15, 2026 | Callos Andrew | EVP, Chief Commercial Officer | A | Non-Qualified Stock Option (Right to Buy) | 29480 | $0.00 | 29,480.0000 | 122,264,929 | 9999.99% | 0.02% |
| March 15, 2026 | Callos Andrew | EVP, Chief Commercial Officer | A | Common Stock | 13320 | $0.00 | 81,824.0000 | 122,264,929 | 19.44% | 0.01% |
| March 16, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 1709 | $61.03 | 46,149.0000 | 122,264,929 | 3.57% | 0.00% |
| March 9, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 2582 | $60.72 | 47,858.0000 | 122,264,929 | 5.12% | 0.00% |
| March 9, 2026 | Blum Robert I | President & CEO | S | Common Stock | 7931 | $60.72 | 395,839.0000 | 122,264,929 | 1.96% | 0.01% |
| March 9, 2026 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2907 | $60.72 | 138,629.0000 | 122,264,929 | 2.05% | 0.00% |
| March 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Non-Qualified Stock Option (Right to Buy) | 15000 | $0.00 | 69,000.0000 | 122,264,929 | 17.86% | 0.01% |
| March 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Non-Qualified Stock Option (Right to Buy) | 11000 | $0.00 | 24,403.0000 | 122,264,929 | 31.07% | 0.01% |
| March 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 11000 | $39.13 | 76,440.0000 | 122,264,929 | 16.81% | 0.01% |
| March 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 15000 | $23.26 | 65,440.0000 | 122,264,929 | 29.74% | 0.01% |
| March 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 11000 | $61.88 | 50,440.0000 | 122,264,929 | 17.90% | 0.01% |
| March 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 15000 | $61.87 | 61,440.0000 | 122,264,929 | 19.62% | 0.01% |
| March 2, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 886 | $37.63 | 51,326.0000 | 122,264,929 | 1.76% | 0.00% |
| March 2, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Incentive Stock Option (Right to Buy) | 886 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.00% |
| March 2, 2026 | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $61.21 | 17,933.0000 | 122,264,929 | 21.80% | 0.00% |
| March 2, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 886 | $61.62 | 50,440.0000 | 122,264,929 | 1.73% | 0.00% |
| Feb. 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Non-Qualified Stock Option (Right to Buy) | 15000 | $0.00 | 84,000.0000 | 122,264,929 | 15.15% | 0.01% |
| Feb. 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 15000 | $23.26 | 65,440.0000 | 122,264,929 | 29.74% | 0.01% |
| Feb. 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 15000 | $61.93 | 50,440.0000 | 122,264,929 | 22.92% | 0.01% |
| Feb. 2, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 886 | $37.63 | 51,326.0000 | 122,264,929 | 1.76% | 0.00% |
| Feb. 2, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 886 | $62.10 | 50,440.0000 | 122,264,929 | 1.73% | 0.00% |
| Feb. 2, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Incentive Stock Option (Right to Buy) | 886 | $0.00 | 886.0000 | 122,264,929 | 50.00% | 0.00% |
| Jan. 15, 2026 | Daly James M | Director | A | Common Stock | 197 | $63.44 | 197.0000 | 122,264,929 | 9999.99% | 0.00% |
| Jan. 15, 2026 | Wysenski Nancy | Director | A | Common Stock | 98 | $63.44 | 30,971.0000 | 122,264,929 | 0.32% | 0.00% |
| Jan. 15, 2026 | WIERENGA WENDELL | Director | A | Common Stock | 98 | $63.44 | 32,542.0000 | 122,264,929 | 0.30% | 0.00% |
| Jan. 15, 2026 | Kaye Edward M. MD | Director | A | Common Stock | 197 | $63.44 | 10,174.0000 | 122,264,929 | 1.97% | 0.00% |
| Jan. 15, 2026 | HENDERSON JOHN T | Director | A | Common Stock | 334 | $63.44 | 74,995.0000 | 122,264,929 | 0.45% | 0.00% |
| Jan. 15, 2026 | Harrington Robert Arthur | Director | A | Common Stock | 197 | $63.44 | 18,739.0000 | 122,264,929 | 1.06% | 0.00% |
| Jan. 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 15000 | $60.28 | 50,440.0000 | 122,264,929 | 22.92% | 0.01% |
| Jan. 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Non-Qualified Stock Option (Right to Buy) | 15000 | $0.00 | 99,000.0000 | 122,264,929 | 13.16% | 0.01% |
| Jan. 5, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 15000 | $23.26 | 65,440.0000 | 122,264,929 | 29.74% | 0.01% |
| Jan. 2, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Incentive Stock Option (Right to Buy) | 885 | $0.00 | 1,772.0000 | 122,264,929 | 33.31% | 0.00% |
| Jan. 2, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 913 | $62.09 | 50,440.0000 | 122,264,929 | 1.78% | 0.00% |
| Jan. 2, 2026 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 885 | $37.63 | 51,325.0000 | 122,264,929 | 1.75% | 0.00% |
| Jan. 2, 2026 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 885 | $63.16 | 50,440.0000 | 122,264,929 | 1.72% | 0.00% |
| Dec. 29, 2025 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 1809 | $62.44 | 51,353.0000 | 122,264,929 | 3.40% | 0.00% |
| Dec. 22, 2025 | Callos Andrew | EVP, Chief Commercial Officer | F | Common Stock | 675 | $62.72 | 53,162.0000 | 122,264,929 | 1.25% | 0.00% |
| Dec. 22, 2025 | Lee Sung | EVP, Chief Financial Officer | F | Common Stock | 805 | $62.72 | 71,416.0000 | 122,264,929 | 1.11% | 0.00% |
| Dec. 22, 2025 | Callos Andrew | EVP, Chief Commercial Officer | A | Common Stock | 1588 | $0.00 | 53,837.0000 | 122,264,929 | 3.04% | 0.00% |
| Dec. 22, 2025 | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 2000 | $0.00 | 142,552.0000 | 122,264,929 | 1.42% | 0.00% |
| Dec. 22, 2025 | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 2000 | $0.00 | 140,552.0000 | 122,264,929 | 1.44% | 0.00% |
| Dec. 22, 2025 | Blum Robert I | President & CEO | F | Common Stock | 2935 | $62.72 | 403,770.0000 | 122,264,929 | 0.72% | 0.00% |
| Dec. 22, 2025 | Blum Robert I | President & CEO | A | Common Stock | 5765 | $0.00 | 400,940.0000 | 122,264,929 | 1.46% | 0.00% |
| Dec. 22, 2025 | Blum Robert I | President & CEO | A | Common Stock | 5765 | $0.00 | 406,705.0000 | 122,264,929 | 1.44% | 0.00% |
| Dec. 22, 2025 | Callos Andrew | EVP, Chief Commercial Officer | A | Common Stock | 1589 | $0.00 | 52,249.0000 | 122,264,929 | 3.14% | 0.00% |
| Dec. 22, 2025 | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 1016 | $62.72 | 141,536.0000 | 122,264,929 | 0.71% | 0.00% |
| Dec. 22, 2025 | Lee Sung | EVP, Chief Financial Officer | A | Common Stock | 2152 | $0.00 | 70,069.0000 | 122,264,929 | 3.17% | 0.00% |
| Dec. 22, 2025 | Lee Sung | EVP, Chief Financial Officer | A | Common Stock | 2152 | $0.00 | 72,221.0000 | 122,264,929 | 3.07% | 0.00% |
| Dec. 22, 2025 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 54727 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.04% |
| Dec. 22, 2025 | Blum Robert I | President & CEO | F | Common Stock | 30426 | $68.18 | 378,669.0000 | 122,264,929 | 7.44% | 0.02% |
| Dec. 22, 2025 | WIERENGA WENDELL | Director | M | Non-Qualified Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.02% |
| Dec. 22, 2025 | WIERENGA WENDELL | Director | S | Common Stock | 20000 | $66.14 | 32,444.0000 | 122,264,929 | 38.14% | 0.02% |
| Dec. 22, 2025 | WIERENGA WENDELL | Director | M | Common Stock | 20000 | $7.61 | 52,444.0000 | 122,264,929 | 61.64% | 0.02% |
| Dec. 22, 2025 | Blum Robert I | President & CEO | M | Incentive Stock Option (Right to Buy) | 16506 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.01% |
| Dec. 22, 2025 | Blum Robert I | President & CEO | M | Common Stock | 16506 | $6.67 | 395,175.0000 | 122,264,929 | 4.36% | 0.01% |
| Dec. 22, 2025 | Blum Robert I | President & CEO | M | Common Stock | 54727 | $6.67 | 409,095.0000 | 122,264,929 | 15.44% | 0.04% |
| Dec. 16, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2200 | $10.60 | 140,752.0000 | 122,264,929 | 1.59% | 0.00% |
| Dec. 16, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2200 | $61.24 | 138,552.0000 | 122,264,929 | 1.56% | 0.00% |
| Dec. 16, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Incentive Stock Option (Right to Buy) | 2200 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.00% |
| Dec. 8, 2025 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 1042 | $65.96 | 50,660.0000 | 122,264,929 | 2.02% | 0.00% |
| Dec. 8, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Non-Qualified Stock Option (Right to Buy) | 1042 | $0.00 | 35,403.0000 | 122,264,929 | 2.86% | 0.00% |
| Dec. 8, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 1042 | $39.13 | 51,702.0000 | 122,264,929 | 2.06% | 0.00% |
| Dec. 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Non-Qualified Stock Option (Right to Buy) | 15858 | $0.00 | 15,857.0000 | 122,264,929 | 50.00% | 0.01% |
| Dec. 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Incentive Stock Option (Right to Buy) | 10628 | $0.00 | 2,657.0000 | 122,264,929 | 80.00% | 0.01% |
| Dec. 3, 2025 | Lee Sung | EVP, Chief Financial Officer | F | Common Stock | 1560 | $65.02 | 67,917.0000 | 122,264,929 | 2.25% | 0.00% |
| Dec. 3, 2025 | Callos Andrew | EVP, Chief Commercial Officer | F | Common Stock | 1368 | $65.02 | 50,660.0000 | 122,264,929 | 2.63% | 0.00% |
| Dec. 3, 2025 | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 2058 | $65.02 | 138,552.0000 | 122,264,929 | 1.46% | 0.00% |
| Dec. 3, 2025 | Blum Robert I | President & CEO | F | Common Stock | 5930 | $65.02 | 354,368.0000 | 122,264,929 | 1.65% | 0.00% |
| Dec. 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 11000 | $39.13 | 76,660.0000 | 122,264,929 | 16.75% | 0.01% |
| Dec. 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 15000 | $23.26 | 65,660.0000 | 122,264,929 | 29.61% | 0.01% |
| Dec. 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 15858 | $37.63 | 92,518.0000 | 122,264,929 | 20.69% | 0.01% |
| Dec. 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 10628 | $37.63 | 103,146.0000 | 122,264,929 | 11.49% | 0.01% |
| Dec. 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 52486 | $65.95 | 50,660.0000 | 122,264,929 | 50.89% | 0.04% |
| Dec. 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Non-Qualified Stock Option (Right to Buy) | 15000 | $0.00 | 114,000.0000 | 122,264,929 | 11.63% | 0.01% |
| Dec. 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Non-Qualified Stock Option (Right to Buy) | 11000 | $0.00 | 36,445.0000 | 122,264,929 | 23.18% | 0.01% |
| Dec. 2, 2025 | HENDERSON JOHN T | Director | M | Common Stock | 8750 | $10.00 | 83,411.0000 | 122,264,929 | 11.72% | 0.01% |
| Dec. 1, 2025 | Kaye Edward M. MD | Director | S | Common Stock | 28064 | $66.72 | 9,977.0000 | 122,264,929 | 73.77% | 0.02% |
| Dec. 1, 2025 | Kaye Edward M. MD | Director | M | Common Stock | 20000 | $14.25 | 38,041.0000 | 122,264,929 | 110.86% | 0.02% |
| Dec. 1, 2025 | Kaye Edward M. MD | Director | M | Common Stock | 8064 | $12.40 | 18,041.0000 | 122,264,929 | 80.83% | 0.01% |
| Dec. 1, 2025 | Kaye Edward M. MD | Director | M | Non-Qualified Stock Option (Right to Buy) | 8064 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.01% |
| Dec. 1, 2025 | Kaye Edward M. MD | Director | M | Non-Qualified Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.02% |
| Dec. 1, 2025 | Harrington Robert Arthur | Director | S | Common Stock | 2150 | $66.80 | 18,542.0000 | 122,264,929 | 10.39% | 0.00% |
| Dec. 2, 2025 | HENDERSON JOHN T | Director | S | Common Stock | 8750 | $63.90 | 74,661.0000 | 122,264,929 | 10.49% | 0.01% |
| Dec. 2, 2025 | HENDERSON JOHN T | Director | M | Non-Qualified Stock Option (Right to Buy) | 8750 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.01% |
| Dec. 2, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2200 | $10.60 | 142,810.0000 | 122,264,929 | 1.56% | 0.00% |
| Dec. 2, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2200 | $63.89 | 140,610.0000 | 122,264,929 | 1.54% | 0.00% |
| Dec. 2, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Incentive Stock Option (Right to Buy) | 2200 | $0.00 | 2,200.0000 | 122,264,929 | 50.00% | 0.00% |
| Nov. 19, 2025 | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $64.73 | 22,933.0000 | 122,264,929 | 17.90% | 0.00% |
| Nov. 18, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Incentive Stock Option (Right to Buy) | 2200 | $0.00 | 4,400.0000 | 122,264,929 | 33.33% | 0.00% |
| Nov. 18, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2200 | $10.60 | 142,810.0000 | 122,264,929 | 1.56% | 0.00% |
| Nov. 18, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2200 | $66.45 | 140,610.0000 | 122,264,929 | 1.54% | 0.00% |
| Nov. 14, 2025 | Hessekiel Jeffrey | Chief Legal & Admin Officer | A | Common Stock | 87297 | $0.00 | 87,297.0000 | 122,264,929 | 9999.99% | 0.07% |
| Nov. 11, 2025 | Kaye Edward M. MD | Director | S | Common Stock | 5175 | $65.08 | 9,977.0000 | 122,264,929 | 34.15% | 0.00% |
| Nov. 11, 2025 | Kaye Edward M. MD | Director | M | Non-Qualified Stock Option (Right to Buy) | 5175 | $0.00 | 0.0000 | 122,264,929 | 100.00% | 0.00% |
| Nov. 11, 2025 | Kaye Edward M. MD | Director | M | Common Stock | 5175 | $9.66 | 15,152.0000 | 122,264,929 | 51.87% | 0.00% |
| Nov. 5, 2025 | Blum Robert I | President & CEO | G | Common Stock | 2000 | $0.00 | 360,274.0000 | 122,264,929 | 0.55% | 0.00% |
| Nov. 4, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Incentive Stock Option (Right to Buy) | 2295 | $0.00 | 6,600.0000 | 122,264,929 | 25.80% | 0.00% |
| Nov. 4, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2295 | $10.60 | 142,905.0000 | 122,264,929 | 1.63% | 0.00% |
| Nov. 4, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2295 | $59.55 | 140,610.0000 | 122,264,929 | 1.61% | 0.00% |
| Oct. 30, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $62.86 | 362,274.0000 | 118,410,689 | 1.36% | 0.00% |
| Oct. 27, 2025 | WIERENGA WENDELL | Director | S | Common Stock | 4375 | $58.68 | 32,444.0000 | 118,410,689 | 11.88% | 0.00% |
| Oct. 27, 2025 | WIERENGA WENDELL | Director | M | Non-Qualified Stock Option (Right to Buy) | 4375 | $0.00 | 0.0000 | 118,410,689 | 100.00% | 0.00% |
| Oct. 27, 2025 | WIERENGA WENDELL | Director | M | Common Stock | 4375 | $10.00 | 36,819.0000 | 118,410,689 | 13.48% | 0.00% |
| Oct. 21, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2105 | $58.22 | 140,610.0000 | 118,410,689 | 1.47% | 0.00% |
| Oct. 15, 2025 | WIERENGA WENDELL | Director | A | Common Stock | 99 | $62.80 | 32,444.0000 | 118,410,689 | 0.31% | 0.00% |
| Oct. 21, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2105 | $0.00 | 1,000.0000 | 118,410,689 | 67.79% | 0.00% |
| Oct. 21, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2105 | $10.60 | 142,715.0000 | 118,410,689 | 1.50% | 0.00% |
| Oct. 15, 2025 | Wysenski Nancy | Director | A | Common Stock | 99 | $62.80 | 30,873.0000 | 118,410,689 | 0.32% | 0.00% |
| Oct. 16, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $60.03 | 367,274.0000 | 118,410,689 | 1.34% | 0.00% |
| Oct. 15, 2025 | Harrington Robert Arthur | Director | A | Common Stock | 199 | $62.80 | 20,692.0000 | 118,410,689 | 0.97% | 0.00% |
| Oct. 15, 2025 | HENDERSON JOHN T | Director | A | Common Stock | 338 | $62.80 | 74,661.0000 | 118,410,689 | 0.45% | 0.00% |
| Oct. 15, 2025 | Kaye Edward M. MD | Director | A | Common Stock | 199 | $62.80 | 9,977.0000 | 118,410,689 | 2.04% | 0.00% |
| Oct. 7, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $60.56 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| Oct. 7, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| Oct. 7, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 3,105.0000 | 118,410,689 | 39.18% | 0.00% |
| Oct. 6, 2025 | Kaye Edward M. MD | Director | S | Common Stock | 6757 | $60.00 | 9,778.0000 | 118,410,689 | 40.86% | 0.01% |
| Oct. 1, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $55.05 | 372,274.0000 | 118,410,689 | 1.33% | 0.00% |
| Sept. 30, 2025 | Kaye Edward M. MD | Director | S | Common Stock | 6695 | $55.08 | 16,535.0000 | 118,410,689 | 28.82% | 0.01% |
| Sept. 23, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $49.28 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| Sept. 23, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 5,105.0000 | 118,410,689 | 28.15% | 0.00% |
| Sept. 23, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| Sept. 15, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $49.77 | 377,274.0000 | 118,410,689 | 1.31% | 0.00% |
| Sept. 9, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| Sept. 9, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 7,105.0000 | 118,410,689 | 21.97% | 0.00% |
| Sept. 9, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $51.29 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| Sept. 2, 2025 | Harrington Robert Arthur | Director | S | Common Stock | 2150 | $48.67 | 20,493.0000 | 118,410,689 | 9.50% | 0.00% |
| Sept. 2, 2025 | Kaye Edward M. MD | Director | S | Common Stock | 6756 | $50.00 | 23,230.0000 | 118,410,689 | 22.53% | 0.01% |
| Sept. 2, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $48.76 | 382,274.0000 | 118,410,689 | 1.29% | 0.00% |
| Aug. 19, 2025 | Daly James M | Director | A | Non-Qualified Stock Option (Right to Buy) | 27450 | $0.00 | 27,450.0000 | 118,410,689 | 9999.99% | 0.02% |
| Aug. 19, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $38.31 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| Aug. 19, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| Aug. 19, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 9,105.0000 | 118,410,689 | 18.01% | 0.00% |
| Aug. 15, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $38.42 | 387,274.0000 | 118,410,689 | 1.27% | 0.00% |
| Aug. 5, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| Aug. 5, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $36.34 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| Aug. 5, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 11,105.0000 | 118,410,689 | 15.26% | 0.00% |
| July 29, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $36.45 | 392,274.0000 | 118,410,689 | 1.26% | 0.00% |
| July 22, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $37.47 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| July 22, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| July 22, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 13,105.0000 | 118,410,689 | 13.24% | 0.00% |
| July 15, 2025 | HENDERSON JOHN T | Director | A | Common Stock | 559 | $38.01 | 74,323.0000 | 118,410,689 | 0.76% | 0.00% |
| July 15, 2025 | Harrington Robert Arthur | Director | A | Common Stock | 328 | $38.01 | 22,643.0000 | 118,410,689 | 1.47% | 0.00% |
| July 15, 2025 | Kaye Edward M. MD | Director | A | Common Stock | 328 | $38.01 | 29,986.0000 | 118,410,689 | 1.11% | 0.00% |
| July 15, 2025 | WIERENGA WENDALL | Director | A | Common Stock | 164 | $38.01 | 32,345.0000 | 118,410,689 | 0.51% | 0.00% |
| July 15, 2025 | Wysenski Nancy | Director | A | Common Stock | 164 | $38.01 | 30,774.0000 | 118,410,689 | 0.54% | 0.00% |
| July 14, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $38.15 | 397,274.0000 | 118,410,689 | 1.24% | 0.00% |
| July 8, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 15,105.0000 | 118,410,689 | 11.69% | 0.00% |
| July 8, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $33.76 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| July 8, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| July 1, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $33.55 | 402,274.0000 | 118,410,689 | 1.23% | 0.00% |
| June 17, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 17,105.0000 | 118,410,689 | 10.47% | 0.00% |
| June 17, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $32.91 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| June 17, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| June 16, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $33.80 | 407,274.0000 | 118,410,689 | 1.21% | 0.00% |
| June 5, 2025 | Kaye Edward M. MD | Director | S | Common Stock | 3636 | $32.10 | 29,658.0000 | 118,410,689 | 10.92% | 0.00% |
| June 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 8659 | $32.04 | 52,028.0000 | 118,410,689 | 14.27% | 0.01% |
| June 3, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 19,105.0000 | 118,410,689 | 9.48% | 0.00% |
| June 3, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $31.88 | 140,610.0000 | 118,410,689 | 1.40% | 0.00% |
| June 3, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,610.0000 | 118,410,689 | 1.42% | 0.00% |
| June 2, 2025 | Lee Sung | EVP, Chief Financial Officer | F | Common Stock | 4965 | $31.21 | 69,477.0000 | 118,410,689 | 6.67% | 0.00% |
| June 2, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $31.22 | 412,274.0000 | 118,410,689 | 1.20% | 0.00% |
| May 20, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $31.98 | 140,255.0000 | 118,410,689 | 1.41% | 0.00% |
| May 20, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 21,105.0000 | 118,410,689 | 8.66% | 0.00% |
| May 20, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,255.0000 | 118,410,689 | 1.43% | 0.00% |
| May 14, 2025 | Harrington Robert Arthur | Director | A | Common Stock | 7333 | $0.00 | 22,315.0000 | 118,410,689 | 48.95% | 0.01% |
| May 14, 2025 | Harrington Robert Arthur | Director | A | Non-Qualified Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 118,410,689 | 9999.99% | 0.01% |
| May 16, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $30.93 | 416,795.0000 | 118,410,689 | 1.19% | 0.00% |
| May 14, 2025 | PARSHALL B LYNNE | Director | A | Non-Qualified Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 118,410,689 | 9999.99% | 0.01% |
| May 15, 2025 | Bhanji Muna | Director | S | Common Stock | 1454 | $29.73 | 23,510.0000 | 118,410,689 | 5.82% | 0.00% |
| May 14, 2025 | PARSHALL B LYNNE | Director | A | Common Stock | 7333 | $0.00 | 27,933.0000 | 118,410,689 | 35.60% | 0.01% |
| May 14, 2025 | HENDERSON JOHN T | Director | A | Non-Qualified Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 118,410,689 | 9999.99% | 0.01% |
| May 14, 2025 | Bhanji Muna | Director | A | Common Stock | 7333 | $0.00 | 24,964.0000 | 118,410,689 | 41.59% | 0.01% |
| May 14, 2025 | Bhanji Muna | Director | A | Non-Qualified Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 118,410,689 | 9999.99% | 0.01% |
| May 14, 2025 | HENDERSON JOHN T | Director | A | Common Stock | 7333 | $0.00 | 73,764.0000 | 118,410,689 | 11.04% | 0.01% |
| May 14, 2025 | Kaye Edward M. MD | Director | A | Common Stock | 7333 | $0.00 | 33,294.0000 | 118,410,689 | 28.25% | 0.01% |
| May 14, 2025 | Kaye Edward M. MD | Director | A | Non-Qualified Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 118,410,689 | 9999.99% | 0.01% |
| May 14, 2025 | Landry Robert E | Director | A | Common Stock | 7333 | $0.00 | 7,333.0000 | 118,410,689 | 9999.99% | 0.01% |
| May 14, 2025 | Landry Robert E | Director | A | Non-Qualified Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 118,410,689 | 9999.99% | 0.01% |
| May 14, 2025 | WIERENGA WENDALL | Director | A | Common Stock | 7333 | $0.00 | 32,181.0000 | 118,410,689 | 29.51% | 0.01% |
| May 14, 2025 | WIERENGA WENDALL | Director | A | Non-Qualified Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 118,410,689 | 9999.99% | 0.01% |
| May 14, 2025 | Wysenski Nancy | Director | A | Common Stock | 7333 | $0.00 | 30,610.0000 | 118,410,689 | 31.50% | 0.01% |
| May 14, 2025 | Wysenski Nancy | Director | A | Non-Qualified Stock Option (Right to Buy) | 10880 | $0.00 | 10,880.0000 | 118,410,689 | 9999.99% | 0.01% |
| May 6, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $35.01 | 140,255.0000 | 118,410,689 | 1.41% | 0.00% |
| May 6, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 23,105.0000 | 118,410,689 | 7.97% | 0.00% |
| May 6, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,255.0000 | 118,410,689 | 1.43% | 0.00% |
| May 5, 2025 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 4002 | $36.68 | 60,687.0000 | 118,410,689 | 6.19% | 0.00% |
| April 29, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $40.96 | 421,795.0000 | 118,410,689 | 1.17% | 0.00% |
| April 22, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,255.0000 | 118,410,689 | 1.43% | 0.00% |
| April 22, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $38.11 | 140,255.0000 | 118,410,689 | 1.41% | 0.00% |
| April 22, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 25,105.0000 | 118,410,689 | 7.38% | 0.00% |
| April 21, 2025 | WIERENGA WENDALL | Director | M | Common Stock | 20000 | $6.21 | 44,848.0000 | 118,410,689 | 80.49% | 0.02% |
| April 21, 2025 | WIERENGA WENDALL | Director | S | Common Stock | 20000 | $38.46 | 24,848.0000 | 118,410,689 | 44.60% | 0.02% |
| April 21, 2025 | WIERENGA WENDALL | Director | M | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 118,410,689 | 100.00% | 0.02% |
| April 15, 2025 | HENDERSON JOHN T | Director | M | Common Stock | 20000 | $6.21 | 69,621.0000 | 118,410,689 | 40.31% | 0.02% |
| April 15, 2025 | HENDERSON JOHN T | Director | S | Common Stock | 3190 | $38.66 | 66,431.0000 | 118,410,689 | 4.58% | 0.00% |
| April 15, 2025 | HENDERSON JOHN T | Director | M | Stock Option (Right to Buy) | 20000 | $0.00 | 0.0000 | 118,410,689 | 100.00% | 0.02% |
| April 15, 2025 | HENDERSON JOHN T | Director | A | Common Stock | 551 | $38.56 | 66,431.0000 | 118,410,689 | 0.84% | 0.00% |
| April 15, 2025 | Harrington Robert Arthur | Director | A | Common Stock | 324 | $38.56 | 14,982.0000 | 118,410,689 | 2.21% | 0.00% |
| April 15, 2025 | Kaye Edward M. MD | Director | A | Common Stock | 324 | $38.56 | 25,961.0000 | 118,410,689 | 1.26% | 0.00% |
| April 15, 2025 | WIERENGA WENDALL | Director | A | Common Stock | 162 | $38.56 | 24,848.0000 | 118,410,689 | 0.66% | 0.00% |
| April 15, 2025 | Wysenski Nancy | Director | A | Common Stock | 162 | $38.56 | 23,277.0000 | 118,410,689 | 0.70% | 0.00% |
| April 10, 2025 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $36.77 | 426,795.0000 | 118,410,689 | 1.16% | 0.00% |
| April 8, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $36.18 | 140,255.0000 | 118,410,689 | 1.41% | 0.00% |
| April 8, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 27,105.0000 | 118,410,689 | 6.87% | 0.00% |
| April 8, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,255.0000 | 118,410,689 | 1.43% | 0.00% |
| April 7, 2025 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 2886 | $35.78 | 64,689.0000 | 118,410,689 | 4.27% | 0.00% |
| April 3, 2025 | Harrington Robert Arthur | Director | S | Common Stock | 450 | $39.43 | 14,658.0000 | 118,410,689 | 2.98% | 0.00% |
| March 31, 2025 | Blum Robert I | President & CEO | S | Common Stock | 15000 | $40.75 | 431,795.0000 | 118,410,689 | 3.36% | 0.01% |
| March 19, 2025 | Malik Fady Ibraham | EVP Research & Development | G | Common Stock | 200 | $0.00 | 140,255.0000 | 118,410,689 | 0.14% | 0.00% |
| March 18, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 142,455.0000 | 118,410,689 | 1.42% | 0.00% |
| March 18, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $43.58 | 140,455.0000 | 118,410,689 | 1.40% | 0.00% |
| March 18, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 29,105.0000 | 118,410,689 | 6.43% | 0.00% |
| March 14, 2025 | Lee Sung | EVP, Chief Financial Officer | A | Common Stock | 32687 | $0.00 | 74,442.0000 | 118,410,689 | 78.28% | 0.03% |
| March 14, 2025 | Lee Sung | EVP, Chief Financial Officer | A | Incentive Stock Option (Right to Buy) | 9016 | $0.00 | 9,016.0000 | 118,410,689 | 9999.99% | 0.01% |
| March 14, 2025 | Lee Sung | EVP, Chief Financial Officer | A | Non-Qualified Stock Option (Right to Buy) | 41326 | $0.00 | 41,326.0000 | 118,410,689 | 9999.99% | 0.03% |
| March 14, 2025 | Callos Andrew | EVP, Chief Commercial Officer | A | Common Stock | 32687 | $0.00 | 70,350.0000 | 118,410,689 | 86.79% | 0.03% |
| March 14, 2025 | Callos Andrew | EVP, Chief Commercial Officer | A | Incentive Stock Option (Right to Buy) | 2749 | $0.00 | 2,749.0000 | 118,410,689 | 9999.99% | 0.00% |
| March 14, 2025 | Callos Andrew | EVP, Chief Commercial Officer | A | Non-Qualified Stock Option (Right to Buy) | 47593 | $0.00 | 47,593.0000 | 118,410,689 | 9999.99% | 0.04% |
| March 14, 2025 | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 39450 | $0.00 | 144,844.0000 | 118,410,689 | 37.43% | 0.03% |
| March 14, 2025 | Malik Fady Ibraham | EVP Research & Development | A | Incentive Stock Option (Right to Buy) | 2293 | $0.00 | 2,293.0000 | 118,410,689 | 9999.99% | 0.00% |
| March 14, 2025 | Malik Fady Ibraham | EVP Research & Development | A | Non-Qualified Stock Option (Right to Buy) | 58465 | $0.00 | 58,465.0000 | 118,410,689 | 9999.99% | 0.05% |
| March 14, 2025 | Blum Robert I | President & CEO | A | Common Stock | 116096 | $0.00 | 484,443.0000 | 118,410,689 | 31.52% | 0.10% |
| March 14, 2025 | Blum Robert I | President & CEO | A | Incentive Stock Option (Right to Buy) | 2254 | $0.00 | 2,254.0000 | 118,410,689 | 9999.99% | 0.00% |
| March 14, 2025 | Blum Robert I | President & CEO | A | Non-Qualified Stock Option (Right to Buy) | 176547 | $0.00 | 176,547.0000 | 118,410,689 | 9999.99% | 0.15% |
| March 17, 2025 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 2775 | $44.38 | 34,888.0000 | 118,410,689 | 7.37% | 0.00% |
| March 17, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4389 | $44.38 | 101,005.0000 | 118,410,689 | 4.16% | 0.00% |
| March 17, 2025 | Blum Robert I | President & CEO | S | Common Stock | 12648 | $44.38 | 330,699.0000 | 118,410,689 | 3.68% | 0.01% |
| March 17, 2025 | Blum Robert I | President & CEO | S | Common Stock | 25000 | $44.65 | 343,347.0000 | 118,410,689 | 6.79% | 0.02% |
| March 17, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 20900 | $23.26 | 58,563.0000 | 118,410,689 | 55.49% | 0.02% |
| March 17, 2025 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 20900 | $45.14 | 37,663.0000 | 118,410,689 | 35.69% | 0.02% |
| March 17, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Non-Qualified Stock Option (Right to Buy) | 20900 | $0.00 | 129,000.0000 | 118,410,689 | 13.94% | 0.02% |
| March 14, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Common Stock | 100 | $23.26 | 37,763.0000 | 118,410,689 | 0.27% | 0.00% |
| March 14, 2025 | Callos Andrew | EVP, Chief Commercial Officer | M | Non-Qualified Stock Option (Right to Buy) | 100 | $0.00 | 149,900.0000 | 118,410,689 | 0.07% | 0.00% |
| March 14, 2025 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 100 | $45.00 | 37,663.0000 | 118,410,689 | 0.26% | 0.00% |
| March 13, 2025 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 26771 | $43.62 | 37,663.0000 | 118,410,689 | 41.55% | 0.02% |
| March 6, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 8228 | $43.27 | 105,394.0000 | 118,410,689 | 7.24% | 0.01% |
| March 6, 2025 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 3341 | $43.27 | 64,434.0000 | 118,410,689 | 4.93% | 0.00% |
| March 6, 2025 | Blum Robert I | President & CEO | S | Common Stock | 16970 | $43.44 | 368,347.0000 | 118,410,689 | 4.40% | 0.01% |
| March 3, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2449 | $42.88 | 113,622.0000 | 118,410,689 | 2.11% | 0.00% |
| March 3, 2025 | Blum Robert I | President & CEO | S | Common Stock | 8743 | $42.88 | 410,317.0000 | 118,410,689 | 2.09% | 0.01% |
| March 3, 2025 | Callos Andrew | EVP, Chief Commercial Officer | S | Common Stock | 1114 | $42.88 | 67,775.0000 | 118,410,689 | 1.62% | 0.00% |
| March 5, 2025 | Blum Robert I | President & CEO | S | Common Stock | 25000 | $43.23 | 385,317.0000 | 118,410,689 | 6.09% | 0.02% |
| March 4, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 31,105.0000 | 118,410,689 | 6.04% | 0.00% |
| March 4, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 118,071.0000 | 118,410,689 | 1.72% | 0.00% |
| March 4, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $42.50 | 116,071.0000 | 118,410,689 | 1.69% | 0.00% |
| March 4, 2025 | Harrington Robert Arthur | Director | S | Common Stock | 900 | $42.50 | 15,108.0000 | 118,410,689 | 5.62% | 0.00% |
| Feb. 18, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 33,105.0000 | 0 | 5.70% | 0.00% |
| Feb. 18, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 118,071.0000 | 0 | 1.72% | 0.00% |
| Feb. 18, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $45.98 | 116,071.0000 | 0 | 1.69% | 0.00% |
| Feb. 10, 2025 | Landry Robert E | Director | A | Non-Qualified Stock Option (Right to Buy) | 25538 | $0.00 | 25,538.0000 | 0 | 9999.99% | 0.00% |
| Feb. 4, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 118,071.0000 | 0 | 1.72% | 0.00% |
| Feb. 4, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 35,105.0000 | 0 | 5.39% | 0.00% |
| Feb. 4, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $48.06 | 116,071.0000 | 0 | 1.69% | 0.00% |
| Jan. 21, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 37,105.0000 | 0 | 5.11% | 0.00% |
| Jan. 21, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 118,071.0000 | 0 | 1.72% | 0.00% |
| Jan. 21, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $45.92 | 116,071.0000 | 0 | 1.69% | 0.00% |
| Jan. 7, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 2000 | $10.60 | 118,071.0000 | 0 | 1.72% | 0.00% |
| Jan. 7, 2025 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 2000 | $0.00 | 39,105.0000 | 0 | 4.87% | 0.00% |
| Jan. 7, 2025 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $49.32 | 116,071.0000 | 0 | 1.69% | 0.00% |
| Jan. 2, 2025 | Kaye Edward M. MD | Director | A | Common Stock | 255 | $48.93 | 25,637.0000 | 0 | 1.00% | 0.00% |
| Jan. 2, 2025 | Wysenski Nancy | Director | A | Common Stock | 127 | $48.93 | 23,115.0000 | 0 | 0.55% | 0.00% |
| Jan. 2, 2025 | WIERENGA WENDALL | Director | A | Common Stock | 127 | $48.93 | 24,686.0000 | 0 | 0.52% | 0.00% |
| Jan. 2, 2025 | Harrington Robert Arthur | Director | A | Common Stock | 255 | $48.93 | 16,008.0000 | 0 | 1.62% | 0.00% |
| Jan. 2, 2025 | HENDERSON JOHN T | Director | A | Common Stock | 434 | $48.93 | 49,070.0000 | 0 | 0.89% | 0.00% |
| Dec. 16, 2024 | WIERENGA WENDALL | Director | S | Common Stock | 742 | $48.61 | 24,559.0000 | 0 | 2.93% | 0.00% |
| Dec. 16, 2024 | WIERENGA WENDALL | Director | M | Common Stock | 742 | $7.37 | 25,301.0000 | 0 | 3.02% | 0.00% |
| Dec. 16, 2024 | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 742 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 11, 2024 | HENDERSON JOHN T | Director | M | Common Stock | 10092 | $7.37 | 48,636.0000 | 0 | 26.18% | 0.00% |
| Dec. 11, 2024 | HENDERSON JOHN T | Director | M | Non-Qualified Stock Option (Right to Buy) | 10092 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 11, 2024 | HENDERSON JOHN T | Director | M | Non-Qualified Stock Option (Right to Buy) | 1780 | $0.00 | 10,092.0000 | 0 | 14.99% | 0.00% |
| Dec. 11, 2024 | HENDERSON JOHN T | Director | S | Common Stock | 1780 | $50.42 | 38,544.0000 | 0 | 4.41% | 0.00% |
| Dec. 11, 2024 | HENDERSON JOHN T | Director | M | Common Stock | 1780 | $7.37 | 40,324.0000 | 0 | 4.62% | 0.00% |
| Dec. 10, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 10, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $50.63 | 118,071.0000 | 0 | 4.30% | 0.00% |
| Dec. 10, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 123,371.0000 | 0 | 4.49% | 0.00% |
| Dec. 10, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $50.65 | 116,071.0000 | 0 | 1.69% | 0.00% |
| Dec. 3, 2024 | Callos Andrew | EVP, Chief Commercial Officer | F | Common Stock | 1351 | $51.51 | 65,712.0000 | 0 | 2.01% | 0.00% |
| Dec. 3, 2024 | Wong Robert | VP, Chief Accounting Officer | A | Common Stock | 764 | $0.00 | 18,162.0000 | 0 | 4.39% | 0.00% |
| Dec. 3, 2024 | Wong Robert | VP, Chief Accounting Officer | F | Common Stock | 273 | $51.51 | 17,889.0000 | 0 | 1.50% | 0.00% |
| Dec. 3, 2024 | Wong Robert | VP, Chief Accounting Officer | A | Common Stock | 766 | $0.00 | 18,655.0000 | 0 | 4.28% | 0.00% |
| Dec. 3, 2024 | Lee Sung | EVP, Chief Financial Officer | A | Common Stock | 4303 | $0.00 | 38,987.0000 | 0 | 12.41% | 0.00% |
| Dec. 3, 2024 | Lee Sung | EVP, Chief Financial Officer | F | Common Stock | 1536 | $51.51 | 37,451.0000 | 0 | 3.94% | 0.00% |
| Dec. 3, 2024 | Lee Sung | EVP, Chief Financial Officer | A | Common Stock | 4304 | $0.00 | 41,755.0000 | 0 | 11.49% | 0.00% |
| Dec. 3, 2024 | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 4000 | $0.00 | 116,099.0000 | 0 | 3.57% | 0.00% |
| Dec. 3, 2024 | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 2028 | $51.51 | 114,071.0000 | 0 | 1.75% | 0.00% |
| Dec. 3, 2024 | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 4000 | $0.00 | 118,071.0000 | 0 | 3.51% | 0.00% |
| Dec. 3, 2024 | Callos Andrew | EVP, Chief Commercial Officer | A | Common Stock | 3176 | $0.00 | 67,063.0000 | 0 | 4.97% | 0.00% |
| Dec. 3, 2024 | Callos Andrew | EVP, Chief Commercial Officer | A | Common Stock | 3177 | $0.00 | 68,889.0000 | 0 | 4.83% | 0.00% |
| Dec. 3, 2024 | Blum Robert I | President & CEO | A | Common Stock | 11529 | $0.00 | 413,373.0000 | 0 | 2.87% | 0.00% |
| Dec. 3, 2024 | Blum Robert I | President & CEO | F | Common Stock | 5843 | $51.51 | 407,530.0000 | 0 | 1.41% | 0.00% |
| Dec. 3, 2024 | Blum Robert I | President & CEO | A | Common Stock | 11530 | $0.00 | 419,060.0000 | 0 | 2.83% | 0.00% |
| Dec. 2, 2024 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $50.76 | 401,844.0000 | 0 | 1.23% | 0.00% |
| Dec. 2, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 54,727.0000 | 0 | 8.37% | 0.00% |
| Dec. 2, 2024 | Blum Robert I | President & CEO | M | Common Stock | 5000 | $6.67 | 406,844.0000 | 0 | 1.24% | 0.00% |
| Nov. 26, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $50.17 | 113,878.0000 | 0 | 4.45% | 0.00% |
| Nov. 26, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 5,300.0000 | 0 | 50.00% | 0.00% |
| Nov. 26, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $50.14 | 111,878.0000 | 0 | 1.76% | 0.00% |
| Nov. 25, 2024 | WIERENGA WENDALL | Director | M | Common Stock | 742 | $7.37 | 25,301.0000 | 0 | 3.02% | 0.00% |
| Nov. 25, 2024 | WIERENGA WENDALL | Director | S | Common Stock | 742 | $50.00 | 24,559.0000 | 0 | 2.93% | 0.00% |
| Nov. 25, 2024 | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 742 | $0.00 | 742.0000 | 0 | 50.00% | 0.00% |
| Nov. 26, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 119,178.0000 | 0 | 4.65% | 0.00% |
| Nov. 18, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 59,727.0000 | 0 | 7.72% | 0.00% |
| Nov. 18, 2024 | Blum Robert I | President & CEO | M | Common Stock | 5000 | $6.67 | 406,622.0000 | 0 | 1.24% | 0.00% |
| Nov. 18, 2024 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $50.55 | 401,622.0000 | 0 | 1.23% | 0.00% |
| Nov. 12, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 1042 | $58.48 | 113,878.0000 | 0 | 0.91% | 0.00% |
| Nov. 12, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 120,220.0000 | 0 | 4.61% | 0.00% |
| Nov. 12, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $58.48 | 114,920.0000 | 0 | 4.41% | 0.00% |
| Nov. 12, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 10,600.0000 | 0 | 33.33% | 0.00% |
| Nov. 1, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 64,727.0000 | 0 | 7.17% | 0.00% |
| Nov. 1, 2024 | Blum Robert I | President & CEO | M | Common Stock | 5000 | $6.67 | 406,622.0000 | 0 | 1.24% | 0.00% |
| Nov. 1, 2024 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $51.63 | 401,622.0000 | 0 | 1.23% | 0.00% |
| Oct. 30, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $51.93 | 114,920.0000 | 0 | 1.71% | 0.00% |
| Oct. 28, 2024 | WIERENGA WENDALL | Director | M | Common Stock | 4452 | $7.37 | 29,011.0000 | 0 | 18.13% | 0.00% |
| Oct. 30, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 122,220.0000 | 0 | 4.53% | 0.00% |
| Oct. 30, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $51.90 | 116,920.0000 | 0 | 4.34% | 0.00% |
| Oct. 28, 2024 | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 4452 | $0.00 | 1,484.0000 | 0 | 75.00% | 0.00% |
| Oct. 30, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 15,900.0000 | 0 | 25.00% | 0.00% |
| Oct. 28, 2024 | WIERENGA WENDALL | Director | S | Common Stock | 4452 | $52.25 | 24,559.0000 | 0 | 15.35% | 0.00% |
| Oct. 15, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $54.18 | 118,920.0000 | 0 | 4.27% | 0.00% |
| Oct. 15, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 21,200.0000 | 0 | 20.00% | 0.00% |
| Oct. 15, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $54.20 | 116,920.0000 | 0 | 1.68% | 0.00% |
| Oct. 15, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 124,220.0000 | 0 | 4.46% | 0.00% |
| Oct. 9, 2024 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $55.61 | 401,622.0000 | 0 | 1.23% | 0.00% |
| Oct. 9, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 69,727.0000 | 0 | 6.69% | 0.00% |
| Oct. 9, 2024 | Blum Robert I | President & CEO | M | Common Stock | 5000 | $6.67 | 406,622.0000 | 0 | 1.24% | 0.00% |
| Oct. 1, 2024 | Kaye Edward M. MD | Director | A | Common Stock | 237 | $52.60 | 25,382.0000 | 0 | 0.94% | 0.00% |
| Oct. 1, 2024 | Wysenski Nancy | Director | A | Common Stock | 118 | $52.60 | 22,988.0000 | 0 | 0.52% | 0.00% |
| Oct. 1, 2024 | Harrington Robert Arthur | Director | A | Common Stock | 237 | $52.60 | 15,753.0000 | 0 | 1.53% | 0.00% |
| Oct. 1, 2024 | HENDERSON JOHN T | Director | A | Common Stock | 403 | $52.60 | 38,544.0000 | 0 | 1.06% | 0.00% |
| Oct. 1, 2024 | WIERENGA WENDALL | Director | A | Common Stock | 118 | $52.60 | 24,559.0000 | 0 | 0.48% | 0.00% |
| Oct. 1, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 124,220.0000 | 0 | 4.46% | 0.00% |
| Oct. 1, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 26,500.0000 | 0 | 16.67% | 0.00% |
| Oct. 1, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $52.11 | 118,920.0000 | 0 | 1.65% | 0.00% |
| Oct. 1, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $52.09 | 118,920.0000 | 0 | 4.27% | 0.00% |
| Sept. 30, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 74,727.0000 | 0 | 6.27% | 0.00% |
| Sept. 30, 2024 | Blum Robert I | President & CEO | M | Common Stock | 5000 | $6.67 | 406,622.0000 | 0 | 1.24% | 0.00% |
| Sept. 30, 2024 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $52.14 | 401,622.0000 | 0 | 1.23% | 0.00% |
| Sept. 17, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 128,220.0000 | 0 | 4.31% | 0.00% |
| Sept. 17, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $56.77 | 122,920.0000 | 0 | 4.13% | 0.00% |
| Sept. 17, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $56.76 | 120,920.0000 | 0 | 1.63% | 0.00% |
| Sept. 16, 2024 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $55.99 | 401,622.0000 | 0 | 1.23% | 0.00% |
| Sept. 17, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 31,800.0000 | 0 | 14.29% | 0.00% |
| Sept. 16, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 79,727.0000 | 0 | 5.90% | 0.00% |
| Sept. 16, 2024 | Blum Robert I | President & CEO | M | Common Stock | 5000 | $6.67 | 406,622.0000 | 0 | 1.24% | 0.00% |
| Sept. 9, 2024 | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 9, 2024 | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $21.61 | 25,600.0000 | 0 | 24.27% | 0.00% |
| Sept. 9, 2024 | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $54.92 | 20,600.0000 | 0 | 19.53% | 0.00% |
| Sept. 3, 2024 | Blum Robert I | President & CEO | S | Common Stock | 5000 | $57.03 | 401,622.0000 | 0 | 1.23% | 0.00% |
| Sept. 3, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 128,220.0000 | 0 | 4.31% | 0.00% |
| Sept. 3, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2084 | $56.99 | 122,920.0000 | 0 | 1.67% | 0.00% |
| Sept. 3, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $57.02 | 122,920.0000 | 0 | 4.13% | 0.00% |
| Sept. 3, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 37,100.0000 | 0 | 12.50% | 0.00% |
| Sept. 3, 2024 | Blum Robert I | President & CEO | M | Common Stock | 5000 | $6.67 | 406,622.0000 | 0 | 1.24% | 0.00% |
| Sept. 3, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 84,727.0000 | 0 | 5.57% | 0.00% |
| Aug. 30, 2024 | Pletcher Brett A | EVP, Chief Legal Officer | A | Common Stock | 33140 | $0.00 | 33,140.0000 | 0 | 9999.99% | 0.00% |
| Aug. 30, 2024 | Pletcher Brett A | EVP, Chief Legal Officer | A | Non-Qualified Stock Option (Right to Buy) | 51039 | $0.00 | 51,039.0000 | 0 | 9999.99% | 0.00% |
| Aug. 26, 2024 | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $57.26 | 20,600.0000 | 0 | 19.53% | 0.00% |
| Aug. 26, 2024 | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 50.00% | 0.00% |
| Aug. 26, 2024 | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $21.61 | 25,600.0000 | 0 | 24.27% | 0.00% |
| Aug. 20, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $56.26 | 125,004.0000 | 0 | 4.07% | 0.00% |
| Aug. 20, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 42,400.0000 | 0 | 11.11% | 0.00% |
| Aug. 20, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $56.23 | 125,004.0000 | 0 | 1.57% | 0.00% |
| Aug. 20, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 130,304.0000 | 0 | 4.24% | 0.00% |
| Aug. 19, 2024 | Blum Robert I | President & CEO | G | Common Stock | 1956 | $0.00 | 401,622.0000 | 0 | 0.48% | 0.00% |
| Aug. 12, 2024 | Blum Robert I | President & CEO | M | Common Stock | 11500 | $6.67 | 415,078.0000 | 0 | 2.85% | 0.00% |
| Aug. 12, 2024 | Blum Robert I | President & CEO | S | Common Stock | 11500 | $55.17 | 403,578.0000 | 0 | 2.77% | 0.00% |
| Aug. 12, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 11500 | $0.00 | 89,727.0000 | 0 | 11.36% | 0.00% |
| Aug. 12, 2024 | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $21.61 | 25,600.0000 | 0 | 24.27% | 0.00% |
| Aug. 12, 2024 | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $55.20 | 20,600.0000 | 0 | 19.53% | 0.00% |
| Aug. 12, 2024 | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 10,000.0000 | 0 | 33.33% | 0.00% |
| Aug. 7, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 127,004.0000 | 0 | 4.35% | 0.00% |
| Aug. 6, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $53.74 | 121,704.0000 | 0 | 1.62% | 0.00% |
| Aug. 6, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $53.70 | 123,704.0000 | 0 | 4.11% | 0.00% |
| Aug. 7, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 47,700.0000 | 0 | 10.00% | 0.00% |
| July 29, 2024 | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $21.61 | 25,600.0000 | 0 | 24.27% | 0.00% |
| July 29, 2024 | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $59.84 | 20,600.0000 | 0 | 19.53% | 0.00% |
| July 29, 2024 | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 15,000.0000 | 0 | 25.00% | 0.00% |
| July 30, 2024 | Blum Robert I | President & CEO | M | Common Stock | 11500 | $6.67 | 415,078.0000 | 0 | 2.85% | 0.00% |
| July 30, 2024 | Blum Robert I | President & CEO | S | Common Stock | 11500 | $59.49 | 403,578.0000 | 0 | 2.77% | 0.00% |
| July 30, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 11500 | $0.00 | 101,227.0000 | 0 | 10.20% | 0.00% |
| July 23, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $57.02 | 129,004.0000 | 0 | 1.53% | 0.00% |
| July 23, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 134,304.0000 | 0 | 4.11% | 0.00% |
| July 23, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $57.02 | 129,004.0000 | 0 | 3.95% | 0.00% |
| July 23, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 53,000.0000 | 0 | 9.09% | 0.00% |
| July 15, 2024 | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $10.68 | 25,600.0000 | 0 | 24.27% | 0.00% |
| July 15, 2024 | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $55.82 | 20,600.0000 | 0 | 19.53% | 0.00% |
| July 15, 2024 | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 10, 2024 | Blum Robert I | President & CEO | M | Common Stock | 5767 | $6.67 | 415,078.0000 | 0 | 1.41% | 0.00% |
| July 10, 2024 | Blum Robert I | President & CEO | S | Common Stock | 11500 | $54.29 | 403,578.0000 | 0 | 2.77% | 0.00% |
| July 10, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 5767 | $0.00 | 112,727.0000 | 0 | 4.87% | 0.00% |
| July 9, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 138,304.0000 | 0 | 3.98% | 0.00% |
| July 9, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $55.91 | 133,004.0000 | 0 | 3.83% | 0.00% |
| July 9, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $55.89 | 131,004.0000 | 0 | 1.50% | 0.00% |
| July 9, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 58,300.0000 | 0 | 8.33% | 0.00% |
| July 5, 2024 | Harrington Robert Arthur | Director | S | Common Stock | 253 | $54.61 | 15,516.0000 | 0 | 1.60% | 0.00% |
| July 1, 2024 | Wysenski Nancy | Director | A | Common Stock | 114 | $0.00 | 22,870.0000 | 0 | 0.50% | 0.00% |
| July 1, 2024 | WIERENGA WENDALL | Director | A | Common Stock | 114 | $0.00 | 24,441.0000 | 0 | 0.47% | 0.00% |
| July 1, 2024 | Kaye Edward M. MD | Director | A | Common Stock | 228 | $0.00 | 25,145.0000 | 0 | 0.92% | 0.00% |
| July 1, 2024 | HENDERSON JOHN T | Director | A | Common Stock | 388 | $0.00 | 38,141.0000 | 0 | 1.03% | 0.00% |
| July 1, 2024 | Harrington Robert Arthur | Director | A | Common Stock | 228 | $0.00 | 15,769.0000 | 0 | 1.47% | 0.00% |
| July 1, 2024 | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $10.68 | 25,600.0000 | 0 | 24.27% | 0.00% |
| July 1, 2024 | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $54.22 | 20,600.0000 | 0 | 19.53% | 0.00% |
| July 1, 2024 | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 50.00% | 0.00% |
| July 1, 2024 | Blum Robert I | President & CEO | S | Common Stock | 11500 | $54.05 | 409,311.0000 | 0 | 2.73% | 0.00% |
| June 25, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2000 | $53.74 | 133,004.0000 | 0 | 1.48% | 0.00% |
| June 25, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5300 | $7.96 | 138,304.0000 | 0 | 3.98% | 0.00% |
| June 25, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5300 | $53.71 | 133,004.0000 | 0 | 3.83% | 0.00% |
| June 25, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5300 | $0.00 | 63,600.0000 | 0 | 7.69% | 0.00% |
| June 17, 2024 | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $10.68 | 25,600.0000 | 0 | 24.27% | 0.00% |
| June 17, 2024 | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $52.55 | 20,600.0000 | 0 | 19.53% | 0.00% |
| June 17, 2024 | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 10,000.0000 | 0 | 33.33% | 0.00% |
| June 17, 2024 | Blum Robert I | President & CEO | S | Common Stock | 11551 | $52.60 | 431,760.0000 | 0 | 2.61% | 0.00% |
| June 17, 2024 | Blum Robert I | President & CEO | S | Common Stock | 10949 | $52.59 | 420,811.0000 | 0 | 2.54% | 0.00% |
| June 11, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 5422 | $53.05 | 137,370.0000 | 0 | 3.80% | 0.00% |
| June 11, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 5422 | $0.00 | 68,900.0000 | 0 | 7.30% | 0.00% |
| June 11, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2366 | $53.03 | 135,004.0000 | 0 | 1.72% | 0.00% |
| June 11, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 5422 | $7.96 | 142,792.0000 | 0 | 3.95% | 0.00% |
| June 10, 2024 | Bhanji Muna | Director | S | Common Stock | 2000 | $52.07 | 17,631.0000 | 0 | 10.19% | 0.00% |
| June 4, 2024 | Blum Robert I | President & CEO | S | Common Stock | 22500 | $48.85 | 443,311.0000 | 0 | 4.83% | 0.00% |
| June 3, 2024 | Harrington Robert Arthur | Director | S | Common Stock | 1580 | $48.64 | 15,541.0000 | 0 | 9.23% | 0.00% |
| June 3, 2024 | PARSHALL B LYNNE | Director | M | Common Stock | 5000 | $10.68 | 20,600.0000 | 0 | 32.05% | 0.00% |
| June 3, 2024 | PARSHALL B LYNNE | Director | S | Common Stock | 5000 | $48.64 | 15,600.0000 | 0 | 24.27% | 0.00% |
| June 3, 2024 | PARSHALL B LYNNE | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 15,000.0000 | 0 | 25.00% | 0.00% |
| May 31, 2024 | Lee Sung | EVP, Chief Financial Officer | A | Common Stock | 34684 | $0.00 | 34,684.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2024 | Lee Sung | EVP, Chief Financial Officer | A | Non-Qualified Stock Option (Right to Buy) | 53417 | $0.00 | 53,417.0000 | 0 | 9999.99% | 0.00% |
| June 3, 2024 | Wong Robert | VP, Chief Accounting Officer | S | Common Stock | 13011 | $48.88 | 16,653.0000 | 0 | 43.86% | 0.00% |
| May 15, 2024 | Bhanji Muna | Director | A | Common Stock | 5600 | $0.00 | 19,631.0000 | 0 | 39.91% | 0.00% |
| May 15, 2024 | Bhanji Muna | Director | A | Non-Qualified Stock Option (Right to Buy) | 3636 | $0.00 | 3,636.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | COSTA SANTO J | Director | A | Common Stock | 5600 | $0.00 | 20,600.0000 | 0 | 37.33% | 0.00% |
| May 15, 2024 | COSTA SANTO J | Director | A | Non-Qualified Stock Option (Right to Buy) | 3636 | $0.00 | 3,636.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Harrington Robert Arthur | Director | A | Common Stock | 5600 | $0.00 | 17,121.0000 | 0 | 48.61% | 0.00% |
| May 15, 2024 | Harrington Robert Arthur | Director | A | Non-Qualified Stock Option (Right to Buy) | 3636 | $0.00 | 3,636.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | HENDERSON JOHN T | Director | A | Common Stock | 5600 | $0.00 | 37,753.0000 | 0 | 17.42% | 0.00% |
| May 15, 2024 | HENDERSON JOHN T | Director | A | Non-Qualified Stock Option (Right to Buy) | 3636 | $0.00 | 3,636.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Kaye Edward M. MD | Director | A | Common Stock | 5600 | $0.00 | 24,917.0000 | 0 | 28.99% | 0.00% |
| May 15, 2024 | Kaye Edward M. MD | Director | A | Non-Qualified Stock Option (Right to Buy) | 3636 | $0.00 | 3,636.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | PARSHALL B LYNNE | Director | A | Common Stock | 5600 | $0.00 | 20,600.0000 | 0 | 37.33% | 0.00% |
| May 15, 2024 | PARSHALL B LYNNE | Director | A | Non-Qualified Stock Option (Right to Buy) | 3636 | $0.00 | 3,636.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | WIERENGA WENDALL | Director | A | Common Stock | 5600 | $0.00 | 24,327.0000 | 0 | 29.90% | 0.00% |
| May 15, 2024 | WIERENGA WENDALL | Director | A | Non-Qualified Stock Option (Right to Buy) | 3636 | $0.00 | 3,636.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Wysenski Nancy | Director | A | Common Stock | 5600 | $0.00 | 22,756.0000 | 0 | 32.64% | 0.00% |
| May 15, 2024 | Wysenski Nancy | Director | A | Non-Qualified Stock Option (Right to Buy) | 3636 | $0.00 | 3,636.0000 | 0 | 9999.99% | 0.00% |
| May 7, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 14186 | $6.67 | 152,603.0000 | 0 | 10.25% | 0.00% |
| May 7, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 14186 | $65.11 | 138,417.0000 | 0 | 9.30% | 0.00% |
| May 7, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 1361 | $65.11 | 137,056.0000 | 0 | 0.98% | 0.00% |
| May 7, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Incentive Stock Option (Right to Buy) | 14186 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 25, 2024 | HENDERSON JOHN T | Director | S | Common Stock | 10562 | $64.54 | 32,153.0000 | 0 | 24.73% | 0.00% |
| April 12, 2024 | Malik Fady Ibraham | EVP Research & Development | G | Common Stock | 150 | $0.00 | 138,417.0000 | 0 | 0.11% | 0.00% |
| April 9, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 28605 | $6.67 | 171,172.0000 | 0 | 20.06% | 0.00% |
| April 9, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 28605 | $74.31 | 142,567.0000 | 0 | 16.71% | 0.00% |
| April 9, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $74.32 | 138,567.0000 | 0 | 2.81% | 0.00% |
| April 9, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 28605 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 14, 2024 | Wong Robert | VP, Chief Accounting Officer | A | Common Stock | 4079 | $0.00 | 29,664.0000 | 0 | 15.94% | 0.00% |
| March 14, 2024 | Wong Robert | VP, Chief Accounting Officer | A | Incentive Stock Option (Right to Buy) | 1403 | $0.00 | 1,403.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | Wong Robert | VP, Chief Accounting Officer | A | Non-Qualified Stock Option (Right to Buy) | 3308 | $0.00 | 3,308.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | Callos Andrew | EVP, Chief Commercial Officer | A | Common Stock | 16941 | $0.00 | 63,887.0000 | 0 | 36.09% | 0.00% |
| March 14, 2024 | Callos Andrew | EVP, Chief Commercial Officer | A | Non-Qualified Stock Option (Right to Buy) | 18346 | $0.00 | 18,346.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | Callos Andrew | EVP, Chief Commercial Officer | A | Incentive Stock Option (Right to Buy) | 1224 | $0.00 | 1,224.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 21333 | $0.00 | 142,567.0000 | 0 | 17.60% | 0.00% |
| March 14, 2024 | Malik Fady Ibraham | EVP Research & Development | A | Incentive Stock Option (Right to Buy) | 1541 | $0.00 | 1,541.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | Malik Fady Ibraham | EVP Research & Development | A | Non-Qualified Stock Option (Right to Buy) | 23103 | $0.00 | 23,103.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | Blum Robert I | President & CEO | A | Common Stock | 61490 | $0.00 | 465,387.0000 | 0 | 15.22% | 0.00% |
| March 14, 2024 | Blum Robert I | President & CEO | A | Incentive Stock Option (Right to Buy) | 1568 | $0.00 | 1,568.0000 | 0 | 9999.99% | 0.00% |
| March 14, 2024 | Blum Robert I | President & CEO | A | Non-Qualified Stock Option (Right to Buy) | 69464 | $0.00 | 69,464.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2024 | Wong Robert | VP, Chief Accounting Officer | F | Common Stock | 1783 | $67.68 | 26,442.0000 | 0 | 6.32% | 0.00% |
| March 6, 2024 | Wong Robert | VP, Chief Accounting Officer | F | Common Stock | 857 | $66.88 | 25,585.0000 | 0 | 3.24% | 0.00% |
| March 4, 2024 | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 9630 | $67.68 | 133,343.0000 | 0 | 6.74% | 0.00% |
| March 6, 2024 | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 8109 | $66.88 | 121,234.0000 | 0 | 6.27% | 0.00% |
| March 4, 2024 | Blum Robert I | President & CEO | F | Common Stock | 25341 | $67.68 | 420,622.0000 | 0 | 5.68% | 0.00% |
| March 6, 2024 | Blum Robert I | President & CEO | F | Common Stock | 16725 | $66.88 | 403,897.0000 | 0 | 3.98% | 0.00% |
| March 4, 2024 | Callos Andrew | EVP, Chief Commercial Officer | F | Common Stock | 2202 | $67.68 | 52,049.0000 | 0 | 4.06% | 0.00% |
| March 6, 2024 | Callos Andrew | EVP, Chief Commercial Officer | F | Common Stock | 5103 | $66.88 | 46,946.0000 | 0 | 9.80% | 0.00% |
| March 5, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $67.53 | 138,973.0000 | 0 | 2.80% | 0.00% |
| March 5, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 28604 | $6.67 | 167,577.0000 | 0 | 20.58% | 0.00% |
| March 5, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 28604 | $67.56 | 138,973.0000 | 0 | 17.07% | 0.00% |
| March 5, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 28604 | $0.00 | 28,605.0000 | 0 | 50.00% | 0.00% |
| Feb. 14, 2024 | HENDERSON JOHN T | Director | M | Common Stock | 5000 | $4.44 | 47,715.0000 | 0 | 11.71% | 0.00% |
| Feb. 14, 2024 | HENDERSON JOHN T | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 14, 2024 | HENDERSON JOHN T | Director | S | Common Stock | 5000 | $76.48 | 42,715.0000 | 0 | 10.48% | 0.00% |
| Feb. 13, 2024 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $6.67 | 458,463.0000 | 0 | 2.80% | 0.00% |
| Feb. 13, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 118,494.0000 | 0 | 9.54% | 0.00% |
| Feb. 13, 2024 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $76.85 | 445,963.0000 | 0 | 2.73% | 0.00% |
| Feb. 6, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 28605 | $6.67 | 175,578.0000 | 0 | 19.46% | 0.00% |
| Feb. 6, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 28605 | $0.00 | 57,209.0000 | 0 | 33.33% | 0.00% |
| Feb. 6, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $79.28 | 142,973.0000 | 0 | 2.72% | 0.00% |
| Feb. 6, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 28605 | $79.30 | 146,973.0000 | 0 | 16.29% | 0.00% |
| Jan. 31, 2024 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $6.67 | 458,463.0000 | 0 | 2.80% | 0.00% |
| Jan. 31, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 130,994.0000 | 0 | 8.71% | 0.00% |
| Jan. 31, 2024 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $79.57 | 445,963.0000 | 0 | 2.73% | 0.00% |
| Jan. 19, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 143,494.0000 | 0 | 8.01% | 0.00% |
| Jan. 19, 2024 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $81.42 | 445,963.0000 | 0 | 2.73% | 0.00% |
| Jan. 19, 2024 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $6.67 | 458,463.0000 | 0 | 2.80% | 0.00% |
| Jan. 12, 2024 | HENDERSON JOHN T | Director | M | Common Stock | 5000 | $4.44 | 47,715.0000 | 0 | 11.71% | 0.00% |
| Jan. 12, 2024 | HENDERSON JOHN T | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 50.00% | 0.00% |
| Jan. 12, 2024 | HENDERSON JOHN T | Director | S | Common Stock | 5000 | $85.14 | 42,715.0000 | 0 | 10.48% | 0.00% |
| Jan. 4, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 11678 | $86.98 | 150,973.0000 | 0 | 7.18% | 0.00% |
| Jan. 4, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Incentive Stock Option (Right to Buy) | 11678 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 4, 2024 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $86.99 | 146,973.0000 | 0 | 2.65% | 0.00% |
| Jan. 4, 2024 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 11678 | $7.96 | 162,651.0000 | 0 | 7.74% | 0.00% |
| Jan. 2, 2024 | HENDERSON JOHN T | Director | A | Common Stock | 252 | $84.12 | 42,715.0000 | 0 | 0.59% | 0.00% |
| Jan. 2, 2024 | SMITH SANDFORD D | Director | A | Common Stock | 148 | $84.12 | 18,801.0000 | 0 | 0.79% | 0.00% |
| Jan. 2, 2024 | WIERENGA WENDALL | Director | A | Common Stock | 74 | $84.12 | 18,727.0000 | 0 | 0.40% | 0.00% |
| Jan. 2, 2024 | Wysenski Nancy | Director | A | Common Stock | 74 | $84.12 | 17,156.0000 | 0 | 0.43% | 0.00% |
| Jan. 2, 2024 | Harrington Robert Arthur | Director | A | Common Stock | 148 | $84.12 | 11,521.0000 | 0 | 1.30% | 0.00% |
| Jan. 2, 2024 | Kaye Edward M. MD | Director | A | Common Stock | 148 | $84.12 | 19,317.0000 | 0 | 0.77% | 0.00% |
| Jan. 2, 2024 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $6.67 | 458,463.0000 | 0 | 2.80% | 0.00% |
| Jan. 2, 2024 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $85.08 | 445,963.0000 | 0 | 2.73% | 0.00% |
| Jan. 2, 2024 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 155,994.0000 | 0 | 7.42% | 0.00% |
| Dec. 27, 2023 | WIERENGA WENDALL | Director | M | Common Stock | 5000 | $4.44 | 23,653.0000 | 0 | 26.81% | 0.00% |
| Dec. 27, 2023 | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 27, 2023 | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 0 | 50.00% | 0.00% |
| Dec. 27, 2023 | WIERENGA WENDALL | Director | S | Common Stock | 5000 | $73.60 | 18,653.0000 | 0 | 21.14% | 0.00% |
| Dec. 27, 2023 | WIERENGA WENDALL | Director | M | Common Stock | 5000 | $4.44 | 23,653.0000 | 0 | 26.81% | 0.00% |
| Dec. 27, 2023 | WIERENGA WENDALL | Director | S | Common Stock | 5000 | $73.60 | 18,653.0000 | 0 | 21.14% | 0.00% |
| Dec. 18, 2023 | HENDERSON JOHN T | Director | M | Common Stock | 13020 | $6.72 | 44,921.0000 | 0 | 40.81% | 0.00% |
| Dec. 18, 2023 | HENDERSON JOHN T | Director | S | Common Stock | 2458 | $36.34 | 42,463.0000 | 0 | 5.47% | 0.00% |
| Dec. 18, 2023 | HENDERSON JOHN T | Director | M | Non-Qualified Stock Option (Right to Buy) | 13020 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 18, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $6.67 | 458,463.0000 | 0 | 2.80% | 0.00% |
| Dec. 18, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $36.95 | 445,963.0000 | 0 | 2.73% | 0.00% |
| Dec. 18, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 168,494.0000 | 0 | 6.91% | 0.00% |
| Nov. 30, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 180,994.0000 | 0 | 6.46% | 0.00% |
| Nov. 30, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $32.99 | 445,583.0000 | 0 | 2.73% | 0.00% |
| Nov. 30, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $6.67 | 458,083.0000 | 0 | 2.81% | 0.00% |
| Nov. 15, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 193,494.0000 | 0 | 6.07% | 0.00% |
| Nov. 15, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $6.67 | 458,083.0000 | 0 | 2.81% | 0.00% |
| Nov. 15, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $34.57 | 445,583.0000 | 0 | 2.73% | 0.00% |
| Nov. 9, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2500 | $35.40 | 150,664.0000 | 0 | 1.63% | 0.00% |
| Oct. 30, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 205,994.0000 | 0 | 5.72% | 0.00% |
| Oct. 30, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $6.67 | 458,083.0000 | 0 | 2.81% | 0.00% |
| Oct. 30, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $32.17 | 445,583.0000 | 0 | 2.73% | 0.00% |
| Oct. 16, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $33.70 | 445,583.0000 | 0 | 2.73% | 0.00% |
| Oct. 16, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 218,494.0000 | 0 | 5.41% | 0.00% |
| Oct. 16, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $6.67 | 458,083.0000 | 0 | 2.81% | 0.00% |
| Oct. 12, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2500 | $35.89 | 153,164.0000 | 0 | 1.61% | 0.00% |
| Oct. 6, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $6.67 | 458,083.0000 | 0 | 2.81% | 0.00% |
| Oct. 6, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $30.00 | 445,583.0000 | 0 | 2.73% | 0.00% |
| Oct. 6, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 230,994.0000 | 0 | 5.13% | 0.00% |
| Oct. 2, 2023 | HENDERSON JOHN T | Director | A | Common Stock | 762 | $27.88 | 31,901.0000 | 0 | 2.45% | 0.00% |
| Oct. 2, 2023 | SMITH SANDFORD D | Director | A | Common Stock | 448 | $27.88 | 18,653.0000 | 0 | 2.46% | 0.00% |
| Oct. 2, 2023 | WIERENGA WENDALL | Director | A | Common Stock | 448 | $27.88 | 18,653.0000 | 0 | 2.46% | 0.00% |
| Oct. 2, 2023 | Wysenski Nancy | Director | A | Common Stock | 224 | $27.88 | 17,082.0000 | 0 | 1.33% | 0.00% |
| Oct. 2, 2023 | Kaye Edward M. MD | Director | A | Common Stock | 448 | $27.88 | 19,169.0000 | 0 | 2.39% | 0.00% |
| Oct. 2, 2023 | Harrington Robert Arthur | Director | A | Common Stock | 448 | $27.88 | 11,373.0000 | 0 | 4.10% | 0.00% |
| Sept. 14, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2500 | $34.86 | 155,664.0000 | 0 | 1.58% | 0.00% |
| Sept. 13, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $6.67 | 458,083.0000 | 0 | 2.81% | 0.00% |
| Sept. 13, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $34.90 | 445,583.0000 | 0 | 2.73% | 0.00% |
| Sept. 13, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 243,494.0000 | 0 | 4.88% | 0.00% |
| Aug. 25, 2023 | Blum Robert I | President & CEO | M | Incentive Stock Option (Right to Buy) | 10000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 25, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 2500 | $0.00 | 255,994.0000 | 0 | 0.97% | 0.00% |
| Aug. 25, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $33.99 | 445,583.0000 | 0 | 2.73% | 0.00% |
| Aug. 25, 2023 | Blum Robert I | President & CEO | M | Common Stock | 10000 | $7.96 | 458,083.0000 | 0 | 2.23% | 0.00% |
| Aug. 25, 2023 | Blum Robert I | President & CEO | M | Common Stock | 2500 | $6.67 | 448,083.0000 | 0 | 0.56% | 0.00% |
| Aug. 21, 2023 | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 6020 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 21, 2023 | WIERENGA WENDALL | Director | S | Common Stock | 6020 | $32.02 | 18,205.0000 | 0 | 24.85% | 0.00% |
| Aug. 21, 2023 | WIERENGA WENDALL | Director | M | Common Stock | 6020 | $6.72 | 24,225.0000 | 0 | 33.07% | 0.00% |
| Dec. 21, 2022 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 155,691.0000 | 0 | 6.04% | 0.00% |
| Aug. 11, 2023 | Blum Robert I | President & CEO | M | Incentive Stock Option (Right to Buy) | 792 | $0.00 | 10,000.0000 | 0 | 7.34% | 0.00% |
| Dec. 21, 2022 | Blum Robert I | President & CEO | S | Common Stock | 10000 | $43.92 | 410,578.0000 | 0 | 2.38% | 0.00% |
| Dec. 21, 2022 | Blum Robert I | President & CEO | M | Common Stock | 10000 | $9.65 | 420,578.0000 | 0 | 2.44% | 0.00% |
| Aug. 11, 2023 | Blum Robert I | President & CEO | M | Incentive Stock Option (Right to Buy) | 11708 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 11, 2023 | Blum Robert I | President & CEO | S | Common Stock | 11708 | $32.37 | 445,583.0000 | 0 | 2.56% | 0.00% |
| Aug. 11, 2023 | Blum Robert I | President & CEO | M | Common Stock | 11708 | $9.65 | 457,291.0000 | 0 | 2.63% | 0.00% |
| Aug. 11, 2023 | Blum Robert I | President & CEO | M | Common Stock | 792 | $7.96 | 446,375.0000 | 0 | 0.18% | 0.00% |
| Aug. 11, 2023 | Blum Robert I | President & CEO | S | Common Stock | 792 | $32.37 | 445,583.0000 | 0 | 0.18% | 0.00% |
| Aug. 10, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2500 | $31.70 | 158,164.0000 | 0 | 1.56% | 0.00% |
| Aug. 1, 2023 | Blum Robert I | President & CEO | S | Common Stock | 1809 | $32.63 | 445,583.0000 | 0 | 0.40% | 0.00% |
| Aug. 1, 2023 | Blum Robert I | President & CEO | M | Incentive Stock Option (Right to Buy) | 1809 | $0.00 | 11,708.0000 | 0 | 13.38% | 0.00% |
| Aug. 1, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 10691 | $0.00 | 10,000.0000 | 0 | 51.67% | 0.00% |
| Aug. 1, 2023 | Blum Robert I | President & CEO | M | Common Stock | 1809 | $9.65 | 447,392.0000 | 0 | 0.41% | 0.00% |
| Aug. 1, 2023 | Blum Robert I | President & CEO | S | Common Stock | 10691 | $32.63 | 445,583.0000 | 0 | 2.34% | 0.00% |
| Aug. 1, 2023 | Blum Robert I | President & CEO | M | Common Stock | 10691 | $9.65 | 456,274.0000 | 0 | 2.40% | 0.00% |
| July 13, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $35.28 | 445,583.0000 | 0 | 2.73% | 0.00% |
| July 13, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $9.65 | 458,083.0000 | 0 | 2.81% | 0.00% |
| July 13, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 20,691.0000 | 0 | 37.66% | 0.00% |
| July 13, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2500 | $35.37 | 160,664.0000 | 0 | 1.53% | 0.00% |
| July 7, 2023 | Bhanji Muna | Director | S | Common Stock | 2000 | $34.12 | 14,031.0000 | 0 | 12.48% | 0.00% |
| July 3, 2023 | Wysenski Nancy | Director | A | Common Stock | 187 | $33.36 | 16,858.0000 | 0 | 1.12% | 0.00% |
| July 3, 2023 | WIERENGA WENDALL | Director | A | Common Stock | 374 | $33.36 | 18,205.0000 | 0 | 2.10% | 0.00% |
| July 3, 2023 | SMITH SANDFORD D | Director | A | Common Stock | 374 | $33.36 | 18,205.0000 | 0 | 2.10% | 0.00% |
| July 3, 2023 | Kaye Edward M. MD | Director | A | Common Stock | 374 | $33.36 | 18,721.0000 | 0 | 2.04% | 0.00% |
| July 3, 2023 | HENDERSON JOHN T | Director | A | Common Stock | 636 | $33.36 | 31,139.0000 | 0 | 2.09% | 0.00% |
| July 3, 2023 | Harrington Robert Arthur | Director | A | Common Stock | 374 | $33.36 | 10,925.0000 | 0 | 3.54% | 0.00% |
| July 3, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $9.65 | 458,083.0000 | 0 | 2.81% | 0.00% |
| July 3, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $32.60 | 445,583.0000 | 0 | 2.73% | 0.00% |
| July 3, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 33,191.0000 | 0 | 27.36% | 0.00% |
| June 12, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 45,691.0000 | 0 | 21.48% | 0.00% |
| June 12, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $9.65 | 458,083.0000 | 0 | 2.81% | 0.00% |
| June 12, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $37.06 | 445,583.0000 | 0 | 2.73% | 0.00% |
| June 8, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 2500 | $38.07 | 163,164.0000 | 0 | 1.51% | 0.00% |
| May 31, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $9.65 | 457,724.0000 | 0 | 2.81% | 0.00% |
| May 31, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $37.67 | 445,224.0000 | 0 | 2.73% | 0.00% |
| May 31, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 58,191.0000 | 0 | 17.68% | 0.00% |
| May 10, 2023 | HENDERSON JOHN T | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | Harrington Robert Arthur | Director | A | Common Stock | 5000 | $0.00 | 10,551.0000 | 0 | 90.07% | 0.00% |
| May 10, 2023 | Harrington Robert Arthur | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | COSTA SANTO J | Director | A | Common Stock | 5000 | $0.00 | 15,000.0000 | 0 | 50.00% | 0.00% |
| May 10, 2023 | COSTA SANTO J | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | Bhanji Muna | Director | A | Common Stock | 5000 | $0.00 | 16,031.0000 | 0 | 45.33% | 0.00% |
| May 10, 2023 | Bhanji Muna | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | SMITH SANDFORD D | Director | A | Common Stock | 5000 | $0.00 | 17,831.0000 | 0 | 38.97% | 0.00% |
| May 10, 2023 | SMITH SANDFORD D | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | WIERENGA WENDALL | Director | A | Common Stock | 5000 | $0.00 | 17,831.0000 | 0 | 38.97% | 0.00% |
| May 10, 2023 | WIERENGA WENDALL | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | Wysenski Nancy | Director | A | Common Stock | 5000 | $0.00 | 16,671.0000 | 0 | 42.84% | 0.00% |
| May 10, 2023 | Wysenski Nancy | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | PARSHALL B LYNNE | Director | A | Common Stock | 5000 | $0.00 | 15,000.0000 | 0 | 50.00% | 0.00% |
| May 10, 2023 | PARSHALL B LYNNE | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | Kaye Edward M. MD | Director | A | Common Stock | 5000 | $0.00 | 18,347.0000 | 0 | 37.46% | 0.00% |
| May 10, 2023 | Kaye Edward M. MD | Director | A | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | HENDERSON JOHN T | Director | A | Common Stock | 5000 | $0.00 | 30,503.0000 | 0 | 19.61% | 0.00% |
| May 16, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $9.65 | 457,724.0000 | 0 | 2.81% | 0.00% |
| May 16, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $37.41 | 445,224.0000 | 0 | 2.73% | 0.00% |
| May 16, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 70,691.0000 | 0 | 15.03% | 0.00% |
| May 15, 2023 | HENDERSON JOHN T | Director | M | Non-Qualified Stock Option (Right to Buy) | 4166 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 15, 2023 | HENDERSON JOHN T | Director | M | Common Stock | 4166 | $6.78 | 29,669.0000 | 0 | 16.34% | 0.00% |
| May 15, 2023 | HENDERSON JOHN T | Director | S | Common Stock | 4166 | $37.77 | 25,503.0000 | 0 | 14.04% | 0.00% |
| May 11, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 1787 | $39.50 | 165,396.0000 | 0 | 1.07% | 0.00% |
| May 3, 2023 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 7000 | $7.96 | 174,183.0000 | 0 | 4.19% | 0.00% |
| May 3, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 7000 | $40.00 | 167,183.0000 | 0 | 4.02% | 0.00% |
| May 3, 2023 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 7000 | $0.00 | 74,322.0000 | 0 | 8.61% | 0.00% |
| April 28, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 83,191.0000 | 0 | 13.06% | 0.00% |
| April 28, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $9.65 | 457,724.0000 | 0 | 2.81% | 0.00% |
| April 28, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $37.68 | 445,224.0000 | 0 | 2.73% | 0.00% |
| April 14, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 95,691.0000 | 0 | 11.55% | 0.00% |
| April 14, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $9.65 | 457,724.0000 | 0 | 2.81% | 0.00% |
| April 14, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $35.61 | 445,224.0000 | 0 | 2.73% | 0.00% |
| April 13, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $34.21 | 167,183.0000 | 0 | 2.34% | 0.00% |
| April 3, 2023 | Wysenski Nancy | Director | A | Common Stock | 149 | $37.71 | 11,671.0000 | 0 | 1.29% | 0.00% |
| April 3, 2023 | WIERENGA WENDALL | Director | A | Common Stock | 298 | $37.71 | 12,831.0000 | 0 | 2.38% | 0.00% |
| April 3, 2023 | SMITH SANDFORD D | Director | A | Common Stock | 298 | $37.71 | 12,831.0000 | 0 | 2.38% | 0.00% |
| April 3, 2023 | Kaye Edward M. MD | Director | A | Common Stock | 298 | $37.71 | 13,347.0000 | 0 | 2.28% | 0.00% |
| April 3, 2023 | HENDERSON JOHN T | Director | A | Common Stock | 530 | $37.71 | 25,503.0000 | 0 | 2.12% | 0.00% |
| April 3, 2023 | Harrington Robert Arthur | Director | A | Common Stock | 298 | $37.71 | 5,551.0000 | 0 | 5.67% | 0.00% |
| March 28, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $9.65 | 457,724.0000 | 0 | 2.81% | 0.00% |
| March 28, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 108,191.0000 | 0 | 10.36% | 0.00% |
| March 28, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $35.05 | 445,224.0000 | 0 | 2.73% | 0.00% |
| March 15, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $9.65 | 457,724.0000 | 0 | 2.81% | 0.00% |
| March 15, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 120,691.0000 | 0 | 9.39% | 0.00% |
| March 15, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $37.26 | 445,224.0000 | 0 | 2.73% | 0.00% |
| March 9, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $39.10 | 171,183.0000 | 0 | 2.28% | 0.00% |
| March 6, 2023 | Malik Fady Ibraham | EVP Research & Development | A | Non-Qualified Stock Option (Right to Buy) | 77445 | $0.00 | 77,445.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 12500 | $0.00 | 133,191.0000 | 0 | 8.58% | 0.00% |
| March 6, 2023 | Blum Robert I | President & CEO | F | Common Stock | 11900 | $39.13 | 362,724.0000 | 0 | 3.18% | 0.00% |
| March 6, 2023 | Blum Robert I | President & CEO | S | Common Stock | 12500 | $39.94 | 374,624.0000 | 0 | 3.23% | 0.00% |
| March 6, 2023 | Blum Robert I | President & CEO | M | Common Stock | 12500 | $9.65 | 387,124.0000 | 0 | 3.34% | 0.00% |
| March 6, 2023 | Jaw Ching | SVP Finance & CFO | F | Common Stock | 2403 | $39.13 | 57,346.0000 | 0 | 4.02% | 0.00% |
| March 6, 2023 | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 4958 | $39.13 | 135,183.0000 | 0 | 3.54% | 0.00% |
| March 6, 2023 | Wong Robert | VP, Chief Accounting Officer | F | Common Stock | 692 | $39.13 | 21,613.0000 | 0 | 3.10% | 0.00% |
| March 6, 2023 | Blum Robert I | President & CEO | A | Non-Qualified Stock Option (Right to Buy) | 162445 | $0.00 | 162,445.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2023 | Blum Robert I | President & CEO | A | Incentive Stock Option (Right to Buy) | 2555 | $0.00 | 2,555.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2023 | Blum Robert I | President & CEO | A | Common Stock | 82500 | $0.00 | 445,224.0000 | 0 | 22.74% | 0.00% |
| March 6, 2023 | Callos Andrew | EVP, Chief Commercial Officer | A | Non-Qualified Stock Option (Right to Buy) | 47445 | $0.00 | 47,445.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2023 | Callos Andrew | EVP, Chief Commercial Officer | A | Incentive Stock Option (Right to Buy) | 2555 | $0.00 | 2,555.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2023 | Callos Andrew | EVP, Chief Commercial Officer | A | Common Stock | 30000 | $0.00 | 53,683.0000 | 0 | 126.67% | 0.00% |
| March 6, 2023 | Jaw Ching | SVP Finance & CFO | A | Non-Qualified Stock Option (Right to Buy) | 47445 | $0.00 | 47,445.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2023 | Jaw Ching | SVP Finance & CFO | A | Incentive Stock Option (Right to Buy) | 2555 | $0.00 | 2,555.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2023 | Jaw Ching | SVP Finance & CFO | A | Common Stock | 30000 | $0.00 | 87,346.0000 | 0 | 52.31% | 0.00% |
| March 6, 2023 | Malik Fady Ibraham | EVP Research & Development | A | Incentive Stock Option (Right to Buy) | 2555 | $0.00 | 2,555.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2023 | Malik Fady Ibraham | EVP Research & Development | A | Common Stock | 40000 | $0.00 | 175,183.0000 | 0 | 29.59% | 0.00% |
| March 6, 2023 | Wong Robert | VP, Chief Accounting Officer | A | Non-Qualified Stock Option (Right to Buy) | 9536 | $0.00 | 9,536.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2023 | Wong Robert | VP, Chief Accounting Officer | A | Incentive Stock Option (Right to Buy) | 2464 | $0.00 | 2,464.0000 | 0 | 9999.99% | 0.00% |
| March 6, 2023 | Wong Robert | VP, Chief Accounting Officer | A | Common Stock | 6000 | $0.00 | 27,613.0000 | 0 | 27.76% | 0.00% |
| March 2, 2023 | Wong Robert | VP, Chief Accounting Officer | F | Common Stock | 2484 | $39.60 | 22,305.0000 | 0 | 10.02% | 0.00% |
| March 2, 2023 | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 10785 | $39.60 | 140,141.0000 | 0 | 7.15% | 0.00% |
| March 2, 2023 | Jaw Ching | SVP Finance & CFO | F | Common Stock | 6225 | $39.60 | 59,749.0000 | 0 | 9.44% | 0.00% |
| March 2, 2023 | Callos Andrew | EVP, Chief Commercial Officer | F | Common Stock | 2202 | $39.60 | 23,683.0000 | 0 | 8.51% | 0.00% |
| March 2, 2023 | Blum Robert I | President & CEO | F | Common Stock | 32724 | $39.60 | 374,624.0000 | 0 | 8.03% | 0.00% |
| Feb. 21, 2023 | Wong Robert | VP, Chief Accounting Officer | S | Common Stock | 2234 | $45.21 | 24,789.0000 | 0 | 8.27% | 0.00% |
| Feb. 16, 2023 | Blum Robert I | President & CEO | F | Common Stock | 3230 | $44.13 | 407,348.0000 | 0 | 0.79% | 0.00% |
| Feb. 16, 2023 | Wong Robert | VP, Chief Accounting Officer | F | Common Stock | 510 | $44.13 | 27,023.0000 | 0 | 1.85% | 0.00% |
| Feb. 16, 2023 | Malik Fady Ibraham | EVP Research & Development | F | Common Stock | 1513 | $44.13 | 150,926.0000 | 0 | 0.99% | 0.00% |
| Feb. 16, 2023 | Jaw Ching | SVP Finance & CFO | F | Common Stock | 1210 | $44.13 | 65,974.0000 | 0 | 1.80% | 0.00% |
| Feb. 16, 2023 | Callos Andrew | EVP, Chief Commercial Officer | F | Common Stock | 969 | $44.13 | 25,885.0000 | 0 | 3.61% | 0.00% |
| Feb. 10, 2023 | Malik Fady Ibraham | EVP Research & Development | G | Common Stock | 150 | $0.00 | 152,439.0000 | 0 | 0.10% | 0.00% |
| Feb. 9, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 7000 | $43.74 | 156,589.0000 | 0 | 4.28% | 0.00% |
| Feb. 9, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $43.73 | 152,589.0000 | 0 | 2.55% | 0.00% |
| Feb. 9, 2023 | Malik Fady Ibraham | EVP Research & Development | M | Common Stock | 7000 | $7.96 | 163,589.0000 | 0 | 4.47% | 0.00% |
| Feb. 9, 2023 | Malik Fady Ibraham | EVP Research & Development | M | Non-Qualified Stock Option (Right to Buy) | 7000 | $0.00 | 81,322.0000 | 0 | 7.93% | 0.00% |
| Feb. 6, 2023 | WIERENGA WENDALL | Director | M | Common Stock | 7000 | $6.72 | 19,533.0000 | 0 | 55.85% | 0.00% |
| Feb. 6, 2023 | WIERENGA WENDALL | Director | M | Non-Qualified Stock Option (Right to Buy) | 7000 | $0.00 | 6,020.0000 | 0 | 53.76% | 0.00% |
| Feb. 6, 2023 | WIERENGA WENDALL | Director | S | Common Stock | 7000 | $45.00 | 12,533.0000 | 0 | 35.84% | 0.00% |
| Feb. 3, 2023 | Jaw Ching | SVP Finance & CFO | M | Common Stock | 15000 | $12.10 | 82,184.0000 | 0 | 22.33% | 0.00% |
| Feb. 3, 2023 | Jaw Ching | SVP Finance & CFO | M | Incentive Stock Option (Right to Buy) | 15000 | $0.00 | 3,056.0000 | 0 | 83.07% | 0.00% |
| Feb. 3, 2023 | Jaw Ching | SVP Finance & CFO | S | Common Stock | 15000 | $45.00 | 67,184.0000 | 0 | 18.25% | 0.00% |
| Feb. 3, 2023 | Wong Robert | VP, Chief Accounting Officer | S | Common Stock | 3004 | $45.00 | 27,533.0000 | 0 | 9.84% | 0.00% |
| Jan. 17, 2023 | Blum Robert I | President & CEO | M | Common Stock | 10000 | $9.65 | 420,578.0000 | 0 | 2.44% | 0.00% |
| Jan. 17, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 145,691.0000 | 0 | 6.42% | 0.00% |
| Jan. 17, 2023 | Blum Robert I | President & CEO | S | Common Stock | 10000 | $42.43 | 410,578.0000 | 0 | 2.38% | 0.00% |
| Jan. 12, 2023 | Malik Fady Ibraham | EVP Research & Development | S | Common Stock | 4000 | $40.47 | 156,589.0000 | 0 | 2.49% | 0.00% |
| Jan. 4, 2023 | Blum Robert I | President & CEO | M | Common Stock | 10000 | $9.65 | 420,578.0000 | 0 | 2.44% | 0.00% |
| Jan. 4, 2023 | Blum Robert I | President & CEO | M | Non-Qualified Stock Option (Right to Buy) | 10000 | $0.00 | 155,691.0000 | 0 | 6.04% | 0.00% |
| Jan. 4, 2023 | Blum Robert I | President & CEO | S | Common Stock | 10000 | $44.24 | 410,578.0000 | 0 | 2.38% | 0.00% |
| Jan. 3, 2023 | HENDERSON JOHN T | Director | A | Common Stock | 450 | $44.35 | 24,973.0000 | 0 | 1.84% | 0.00% |
| Jan. 3, 2023 | SMITH SANDFORD D | Director | A | Common Stock | 253 | $44.35 | 12,533.0000 | 0 | 2.06% | 0.00% |
| Jan. 3, 2023 | WIERENGA WENDALL | Director | A | Common Stock | 253 | $44.35 | 12,533.0000 | 0 | 2.06% | 0.00% |
| Jan. 3, 2023 | Wysenski Nancy | Director | A | Common Stock | 126 | $44.35 | 11,522.0000 | 0 | 1.11% | 0.00% |
| Jan. 3, 2023 | Harrington Robert Arthur | Director | A | Common Stock | 253 | $44.35 | 5,253.0000 | 0 | 5.06% | 0.00% |
| Jan. 3, 2023 | Kaye Edward M. MD | Director | A | Common Stock | 253 | $44.35 | 13,049.0000 | 0 | 1.98% | 0.00% |
| Aug. 18, 2022 | Blum Robert I | President & CEO | G | Common Stock | 3035 | $0.00 | 410,578.0000 | 0 | 0.73% | 0.00% |